Avivagen Inc.
Avivagen Inc. VIVXF Peers
See (VIVXF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VIVXF | $0.00 | N/A | 7.8K | N/A | -$0.04 | N/A |
| MKGAF | $135.05 | -0.70% | 58.7B | 18.35 | $7.36 | +1.62% |
| MKKGY | $26.43 | -0.86% | 57.8B | 17.98 | $1.47 | +2.17% |
| HLNCF | $5.64 | +4.16% | 50.9B | 26.86 | $0.21 | +1.93% |
| TKPHF | $27.60 | -1.53% | 43.4B | 58.72 | $0.47 | +4.82% |
| IPSEY | $29.95 | -1.66% | 39.6B | 24.75 | $1.21 | N/A |
| SDZNY | $53.22 | +2.44% | 22.9B | -2661.00 | -$0.02 | +1.27% |
| TEVJF | $15.58 | -12.47% | 17.9B | -13.55 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOY | $8.38 | -0.30% | 14.2B | 11.96 | $0.70 | +0.84% |
Stock Comparison
VIVXF vs MKGAF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, MKGAF has a market cap of 58.7B. Regarding current trading prices, VIVXF is priced at $0.00, while MKGAF trades at $135.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 18.35. In terms of profitability, VIVXF's ROE is +1.22%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, VIVXF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs MKKGY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, MKKGY has a market cap of 57.8B. Regarding current trading prices, VIVXF is priced at $0.00, while MKKGY trades at $26.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 17.98. In terms of profitability, VIVXF's ROE is +1.22%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, VIVXF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HLNCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HLNCF has a market cap of 50.9B. Regarding current trading prices, VIVXF is priced at $0.00, while HLNCF trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 26.86. In terms of profitability, VIVXF's ROE is +1.22%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, VIVXF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TKPHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TKPHF has a market cap of 43.4B. Regarding current trading prices, VIVXF is priced at $0.00, while TKPHF trades at $27.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 58.72. In terms of profitability, VIVXF's ROE is +1.22%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, VIVXF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs IPSEY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, IPSEY has a market cap of 39.6B. Regarding current trading prices, VIVXF is priced at $0.00, while IPSEY trades at $29.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 24.75. In terms of profitability, VIVXF's ROE is +1.22%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, VIVXF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SDZNY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SDZNY has a market cap of 22.9B. Regarding current trading prices, VIVXF is priced at $0.00, while SDZNY trades at $53.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is -2661.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, VIVXF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TEVJF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TEVJF has a market cap of 17.9B. Regarding current trading prices, VIVXF is priced at $0.00, while TEVJF trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -13.55. In terms of profitability, VIVXF's ROE is +1.22%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, VIVXF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ESALY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, VIVXF is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, VIVXF's ROE is +1.22%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, VIVXF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SGIOY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SGIOY has a market cap of 14.2B. Regarding current trading prices, VIVXF is priced at $0.00, while SGIOY trades at $8.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 11.96. In terms of profitability, VIVXF's ROE is +1.22%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, VIVXF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SGIOF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SGIOF has a market cap of 12.9B. Regarding current trading prices, VIVXF is priced at $0.00, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 10.94. In terms of profitability, VIVXF's ROE is +1.22%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, VIVXF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs BIOVF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, BIOVF has a market cap of 10.4B. Regarding current trading prices, VIVXF is priced at $0.00, while BIOVF trades at $30.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 25.24. In terms of profitability, VIVXF's ROE is +1.22%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, VIVXF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs IPSEF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, VIVXF is priced at $0.00, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 26.17. In terms of profitability, VIVXF's ROE is +1.22%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, VIVXF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SFOSF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SFOSF has a market cap of 8.5B. Regarding current trading prices, VIVXF is priced at $0.00, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, VIVXF's ROE is +1.22%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, VIVXF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ESAIY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ESAIY has a market cap of 7.9B. Regarding current trading prices, VIVXF is priced at $0.00, while ESAIY trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 24.74. In terms of profitability, VIVXF's ROE is +1.22%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, VIVXF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ESALF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ESALF has a market cap of 7.8B. Regarding current trading prices, VIVXF is priced at $0.00, while ESALF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 24.12. In terms of profitability, VIVXF's ROE is +1.22%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, VIVXF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HKMPY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, VIVXF is priced at $0.00, while HKMPY trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 17.67. In terms of profitability, VIVXF's ROE is +1.22%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, VIVXF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HKMPF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, VIVXF is priced at $0.00, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, VIVXF's ROE is +1.22%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, VIVXF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs GZPHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, VIVXF is priced at $0.00, while GZPHF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.57. In terms of profitability, VIVXF's ROE is +1.22%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, VIVXF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs WIBFF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, VIVXF is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, VIVXF's ROE is +1.22%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, VIVXF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HLBBF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HLBBF has a market cap of 4.4B. Regarding current trading prices, VIVXF is priced at $0.00, while HLBBF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 11.96. In terms of profitability, VIVXF's ROE is +1.22%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, VIVXF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LVZPF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LVZPF has a market cap of 3.9B. Regarding current trading prices, VIVXF is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, VIVXF's ROE is +1.22%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, VIVXF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HLUBF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HLUBF has a market cap of 3.5B. Regarding current trading prices, VIVXF is priced at $0.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, VIVXF's ROE is +1.22%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, VIVXF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs APNHY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, APNHY has a market cap of 3.1B. Regarding current trading prices, VIVXF is priced at $0.00, while APNHY trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 12.26. In terms of profitability, VIVXF's ROE is +1.22%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, VIVXF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs INVVY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, VIVXF is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, VIVXF's ROE is +1.22%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, VIVXF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HYPMY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, VIVXF is priced at $0.00, while HYPMY trades at $4.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 21.23. In terms of profitability, VIVXF's ROE is +1.22%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, VIVXF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs IZQVF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, VIVXF is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, VIVXF's ROE is +1.22%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, VIVXF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs APNHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, APNHF has a market cap of 2.8B. Regarding current trading prices, VIVXF is priced at $0.00, while APNHF trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 10.44. In terms of profitability, VIVXF's ROE is +1.22%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, VIVXF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HMDCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, VIVXF is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, VIVXF's ROE is +1.22%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, VIVXF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs DNPUF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, VIVXF is priced at $0.00, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 15.93. In terms of profitability, VIVXF's ROE is +1.22%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, VIVXF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ULIHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, VIVXF is priced at $0.00, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, VIVXF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs THCBF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, VIVXF is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -0.10. In terms of profitability, VIVXF's ROE is +1.22%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, VIVXF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HTSUF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, VIVXF is priced at $0.00, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 15.60. In terms of profitability, VIVXF's ROE is +1.22%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, VIVXF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CHSYF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, VIVXF is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, VIVXF's ROE is +1.22%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, VIVXF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TSMRF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, VIVXF is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, VIVXF's ROE is +1.22%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, VIVXF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs DMPHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, VIVXF is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 18.15. In terms of profitability, VIVXF's ROE is +1.22%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, VIVXF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LJUIF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, VIVXF is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, VIVXF's ROE is +1.22%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, VIVXF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LBTSF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LBTSF has a market cap of 1.9B. Regarding current trading prices, VIVXF is priced at $0.00, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, VIVXF's ROE is +1.22%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, VIVXF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs NPNKF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, VIVXF is priced at $0.00, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 7.61. In terms of profitability, VIVXF's ROE is +1.22%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, VIVXF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs NPPNY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, VIVXF is priced at $0.00, while NPPNY trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 7.26. In terms of profitability, VIVXF's ROE is +1.22%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, VIVXF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SMDPY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, VIVXF is priced at $0.00, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 9.76. In terms of profitability, VIVXF's ROE is +1.22%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, VIVXF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SHEZF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SHEZF has a market cap of 1.6B. Regarding current trading prices, VIVXF is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, VIVXF's ROE is +1.22%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, VIVXF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs MITPF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, VIVXF is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, VIVXF's ROE is +1.22%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, VIVXF is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs YIHCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, VIVXF is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, VIVXF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs KARBF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, VIVXF is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, VIVXF's ROE is +1.22%, compared to KARBF's ROE of N/A. Regarding short-term risk, VIVXF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs EVOTF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, VIVXF is priced at $0.00, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, VIVXF's ROE is +1.22%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, VIVXF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ARSUF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ARSUF has a market cap of 1.5B. Regarding current trading prices, VIVXF is priced at $0.00, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, VIVXF's ROE is +1.22%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, VIVXF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs GTBIF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, VIVXF is priced at $0.00, while GTBIF trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 24.43. In terms of profitability, VIVXF's ROE is +1.22%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, VIVXF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CHIZF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CHIZF has a market cap of 1.2B. Regarding current trading prices, VIVXF is priced at $0.00, while CHIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 12.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, VIVXF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs KSPHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, VIVXF is priced at $0.00, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 14.20. In terms of profitability, VIVXF's ROE is +1.22%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, VIVXF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SWGHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, VIVXF is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 16.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, VIVXF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs GNMLF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, VIVXF is priced at $0.00, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 10.36. In terms of profitability, VIVXF's ROE is +1.22%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, VIVXF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs KKPCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, VIVXF is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 10.46. In terms of profitability, VIVXF's ROE is +1.22%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, VIVXF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CASBF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CASBF has a market cap of 1B. Regarding current trading prices, VIVXF is priced at $0.00, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -15.24. In terms of profitability, VIVXF's ROE is +1.22%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, VIVXF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SHPHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, VIVXF is priced at $0.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, VIVXF's ROE is +1.22%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, VIVXF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LVTTF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LVTTF has a market cap of 894.3M. Regarding current trading prices, VIVXF is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, VIVXF's ROE is +1.22%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, VIVXF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs EVRRF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, EVRRF has a market cap of 893.7M. Regarding current trading prices, VIVXF is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, VIVXF's ROE is +1.22%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, VIVXF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs BIOGY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, VIVXF is priced at $0.00, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, VIVXF's ROE is +1.22%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, VIVXF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs NRXCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, NRXCF has a market cap of 844.9M. Regarding current trading prices, VIVXF is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, VIVXF's ROE is +1.22%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, VIVXF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TWAPF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, VIVXF is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, VIVXF's ROE is +1.22%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, VIVXF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CSWYF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, VIVXF is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, VIVXF's ROE is +1.22%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, VIVXF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TCNNF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TCNNF has a market cap of 752.9M. Regarding current trading prices, VIVXF is priced at $0.00, while TCNNF trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -4.99. In terms of profitability, VIVXF's ROE is +1.22%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, VIVXF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TRXPF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, VIVXF is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, VIVXF's ROE is +1.22%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, VIVXF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SWDCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, VIVXF is priced at $0.00, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, VIVXF's ROE is +1.22%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, VIVXF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs NIKA Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, NIKA has a market cap of 666.7M. Regarding current trading prices, VIVXF is priced at $0.00, while NIKA trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, VIVXF's ROE is +1.22%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, VIVXF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CURLF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CURLF has a market cap of 657.3M. Regarding current trading prices, VIVXF is priced at $0.00, while CURLF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -2.63. In terms of profitability, VIVXF's ROE is +1.22%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, VIVXF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs TRSSF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, VIVXF is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, VIVXF's ROE is +1.22%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, VIVXF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ELTP Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ELTP has a market cap of 598.1M. Regarding current trading prices, VIVXF is priced at $0.00, while ELTP trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -27.99. In terms of profitability, VIVXF's ROE is +1.22%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, VIVXF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CCHWF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, VIVXF is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, VIVXF's ROE is +1.22%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, VIVXF is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs SGFEF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, SGFEF has a market cap of 508.7M. Regarding current trading prices, VIVXF is priced at $0.00, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 22.88. In terms of profitability, VIVXF's ROE is +1.22%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, VIVXF is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs AIHLF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, VIVXF is priced at $0.00, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, VIVXF's ROE is +1.22%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, VIVXF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs BOIRF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, VIVXF is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, VIVXF's ROE is +1.22%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, VIVXF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs PEXXF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, VIVXF is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to PEXXF's ROE of N/A. Regarding short-term risk, VIVXF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs KHTRF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, KHTRF has a market cap of 437.4M. Regarding current trading prices, VIVXF is priced at $0.00, while KHTRF trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 62.71. In terms of profitability, VIVXF's ROE is +1.22%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, VIVXF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs AGYTF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, VIVXF is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, VIVXF's ROE is +1.22%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, VIVXF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs GLASF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, GLASF has a market cap of 297.9M. Regarding current trading prices, VIVXF is priced at $0.00, while GLASF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -63.34. In terms of profitability, VIVXF's ROE is +1.22%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, VIVXF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs PKBFF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, PKBFF has a market cap of 289.4M. Regarding current trading prices, VIVXF is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, VIVXF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs BHCCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, VIVXF is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, VIVXF's ROE is +1.22%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, VIVXF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CRLBF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CRLBF has a market cap of 243.7M. Regarding current trading prices, VIVXF is priced at $0.00, while CRLBF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.28. In terms of profitability, VIVXF's ROE is +1.22%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, VIVXF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CPHRF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CPHRF has a market cap of 229.3M. Regarding current trading prices, VIVXF is priced at $0.00, while CPHRF trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 24.86. In terms of profitability, VIVXF's ROE is +1.22%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, VIVXF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs PLNHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, VIVXF is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, VIVXF's ROE is +1.22%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, VIVXF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs VRNOF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, VRNOF has a market cap of 192.1M. Regarding current trading prices, VIVXF is priced at $0.00, while VRNOF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -0.53. In terms of profitability, VIVXF's ROE is +1.22%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, VIVXF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HUMDF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, VIVXF is priced at $0.00, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, VIVXF's ROE is +1.22%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, VIVXF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs PHCUF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, PHCUF has a market cap of 133.5M. Regarding current trading prices, VIVXF is priced at $0.00, while PHCUF trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 501.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, VIVXF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs COPHF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, VIVXF is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, VIVXF's ROE is +1.22%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, VIVXF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs DUTV Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, DUTV has a market cap of 129.2M. Regarding current trading prices, VIVXF is priced at $0.00, while DUTV trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, VIVXF's ROE is +1.22%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, VIVXF is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs STMH Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, STMH has a market cap of 126.5M. Regarding current trading prices, VIVXF is priced at $0.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas STMH's P/E ratio is N/A. In terms of profitability, VIVXF's ROE is +1.22%, compared to STMH's ROE of -2.75%. Regarding short-term risk, VIVXF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs HLTRF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, HLTRF has a market cap of 115.8M. Regarding current trading prices, VIVXF is priced at $0.00, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -5.63. In terms of profitability, VIVXF's ROE is +1.22%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, VIVXF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LPCUF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, VIVXF is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, VIVXF's ROE is +1.22%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, VIVXF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CNVCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, VIVXF is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, VIVXF's ROE is +1.22%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, VIVXF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs BIOYF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, BIOYF has a market cap of 97.6M. Regarding current trading prices, VIVXF is priced at $0.00, while BIOYF trades at $8.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 17.37. In terms of profitability, VIVXF's ROE is +1.22%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, VIVXF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs ABSCF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, ABSCF has a market cap of 95M. Regarding current trading prices, VIVXF is priced at $0.00, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -9.41. In terms of profitability, VIVXF's ROE is +1.22%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, VIVXF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LRDSF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, VIVXF is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, VIVXF's ROE is +1.22%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, VIVXF is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs GBLP Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, VIVXF is priced at $0.00, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas GBLP's P/E ratio is -0.67. In terms of profitability, VIVXF's ROE is +1.22%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, VIVXF is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs GRUSF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, GRUSF has a market cap of 83M. Regarding current trading prices, VIVXF is priced at $0.00, while GRUSF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is -6.70. In terms of profitability, VIVXF's ROE is +1.22%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, VIVXF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs LOVFF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, LOVFF has a market cap of 80.9M. Regarding current trading prices, VIVXF is priced at $0.00, while LOVFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 8.85. In terms of profitability, VIVXF's ROE is +1.22%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, VIVXF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs CBWTF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, CBWTF has a market cap of 76.4M. Regarding current trading prices, VIVXF is priced at $0.00, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 2.90. In terms of profitability, VIVXF's ROE is +1.22%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, VIVXF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs EOFBY Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, VIVXF is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, VIVXF's ROE is +1.22%, compared to EOFBY's ROE of N/A. Regarding short-term risk, VIVXF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs AAWH Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, AAWH has a market cap of 71.4M. Regarding current trading prices, VIVXF is priced at $0.00, while AAWH trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.87. In terms of profitability, VIVXF's ROE is +1.22%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, VIVXF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.
VIVXF vs MEDXF Comparison
VIVXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIVXF stands at 7.8K. In comparison, MEDXF has a market cap of 68.4M. Regarding current trading prices, VIVXF is priced at $0.00, while MEDXF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIVXF currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is 14.13. In terms of profitability, VIVXF's ROE is +1.22%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, VIVXF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for VIVXF.